Back to mobile site

Orchestra BioMed Inc. (OBIO) PT Lowered to $9 at Jefferies

March 26, 2026 10:56 AM EDT Send to a Friend
Jefferies analyst Matthew Taylor lowered the price target on Orchestra BioMed Inc. (NASDAQ: OBIO) to $9.00 (from $10.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login